1. Shankar J, Restrepo A, Clemons KV, Stevens DA. Hormones and the resistance of women to paracoccidioidomycosis. Clin Microbiol Rev. 2011;24:296-313.

https://doi.org/10.1128/CMR.00062-10

PMid:21482727 PMCid:PMC3122492

2. Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC. Neglected endemic mycoses. Lancet Infect Dis. 2017;17:367-77.

https://doi.org/10.1016/S1473-3099(17)30306-7

PMid:28774696 

3. Verli FD, Marinho SA, Souza SC, Figueiredo MA, Yurgel LS. Perfil clínico-epidemiológico dos pacientes portadores de paracoccidioidomicose no Serviço de Estomatologia do Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul. Rev Soc Bras Med Trop. 2005;38:234-7.

https://doi.org/10.1590/S0037-86822005000300005

PMid:15895174 

4. Caixeta CA, de Carli ML, Ribeiro-Júnior NV, Sperandio FF, Nonogaki S, Nogueira DA, et al. Estrogen receptor-alfa correlates with higher fungal cell number in oral paracoccidioidomycosis in women. Mycopathologia. 2018;183:785-91.

https://doi.org/10.1007/s11046-018-0272-7

PMid:29796757 

5. Almeida OP, Jorge-Júnior J, Scully C. Paracoccidioidomycosis of the mouth: an emerging deep mycosis. Crit Rev Oral Biol Med. 2003;14:377-83.

https://doi.org/10.1177/154411130301400508

PMid:14530306 

6. Silva CO, Almeida AS, Pereira AA, Sallum AW, Hanemann JA, Tatakis DN. Gingival involvement in oral paracoccidioidomycosis. J Periodontol. 2007;78:1229-34.

https://doi.org/10.1902/jop.2007.060490

PMid:17608577 

7. Abreu e Silva MA, Salum FG, Figueiredo MA, Lopes TG, da Silva VD, Cherubini K. Interrelationship of clinical, histomorphometric and immunohistochemical features of oral lesions in chronic paracoccidioidomycosis. J Oral Pathol Med. 2013;42:235-42.

https://doi.org/10.1111/jop.12018

PMid:23157441 

8. Carli ML, Cardoso BC, Malaquias LC, Nonogaki S, Pereira AA, Sperandio FF, et al. Serum antibody levels correlate with oral fungal cell numbers and influence the patients' response to chronic paracoccidioidomycosis. Mycoses. 2015;58:356-61.

https://doi.org/10.1111/myc.12325

PMid:25851750 

9. Rodrigues-Vendramini FAV, Marschalk C, Toplak M, Macheroux P, Bonfim-Mendonça PS, Svidzinski TIE, et al. Promising new antifungal treatment targeting chorismate synthase from Paracoccidioides brasiliensis. Antimicrob Agents Chemother. 2019;63:01097-18.

https://doi.org/10.1128/AAC.01097-18

PMid:30348661 PMCid:PMC6325199

10. Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, et al. Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. 2018;19:1264.

https://doi.org/10.3390/ijms19041264

PMid:29690653 PMCid:PMC5979509

11. Apte RS, Chen DS, Ferrara N. Signaling and disease: beyond discovery and development. Cell. 2019;176:1248-64.

https://doi.org/10.1016/j.cell.2019.01.021

PMid:30849371 PMCid:PMC6410740

12. Valiatti FB, Crispim D, Benfica C, Valiatti BB, Kramer CK, Canani LH. The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy. Arq Bras Endocrinol Metabol. 2011;55:106-13.

https://doi.org/10.1590/S0004-27302011000200002

PMid:21584427 

13. Vempati P, Popel AS, Mac Gabhann F. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. Cytokine Growth Factor Rev. 2014;25:1-19.

https://doi.org/10.1016/j.cytogfr.2013.11.002

PMid:24332926 PMCid:PMC3977708

14. Vasconcelos RC, Costa AL, Freitas RA, Bezerra BA, Santos BR, Pinto LP, et al. Immunoexpression of HIF-1 alfa and VEGF in peridontal disease and healthy gingival tissues. Braz Dent J. 2016;27:117-22.

https://doi.org/10.1590/0103-6440201600533

PMid:27058371 

15. Ferreira MC, Gameiro J, Nagib PR, Brito VN, Vasconcellos EC, Verinaud L. Effect of low intensity helium- neon (HeNe) laser irradiation on experimental paracoccidioidomycotic wound healing dynamics. Photochem Photobiol. 2009;85:227-33.

https://doi.org/10.1111/j.1751-1097.2008.00423.x

PMid:18764901 

16. Klein M, Picard E, Vignaud JM, Marie B, Bresler L, Toussaint B, et al. Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma. J Endocrinol. 1999;161:41-9.

https://doi.org/10.1677/joe.0.1610041

PMid:10194527 

17. Klein M, Vignaud JM, Hennequin V, Toussaint B, Bresler L, Plénat F, et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001;86:656-8.

https://doi.org/10.1210/jcem.86.2.7226

PMid:11158026 

18. Shikanai-Yasuda MA, Mendes RP, Colombo AL, Queiroz-Telles F, Kono ASG, Paniago AMM, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;50:715-40.

https://doi.org/10.1590/0037-8682-0230-2017

PMid:28746570 

19. Magalhães EM, Ribeiro CF, Dâmaso CS, Coelho LF, Silva RR, Ferreira EB, et al. Prevalence of paracoccidioidomycosis infection by intradermal reaction in rural areas in Alfenas, Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo. 2014;56:281-5.

https://doi.org/10.1590/S0036-46652014000400002

PMid:25076426 PMCid:PMC4131811

20. Mendes RP, Cavalcante RS, Marques SA, Marques MEA, Venturini J, Sylvestre TF, et al. Paracoccidioidomycosis: current perspectives from Brazil. Open Microbiol J. 2017;31:224-82.

https://doi.org/10.2174/1874285801711010224

PMid:29204222 PMCid:PMC5695158

21. Brazão-Silva MT, Andrade MF, Franco T, Ribeiro RI, Silva WS, Faria G, et al. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2010;54:e189-95.

https://doi.org/10.1111/j.1439-0507.2010.01873.x

PMid:20406390 

22. Arruda JAA, Schuch LF, Abreu LG, Silva LVO, Mosconi C, Monteiro JLGC, et al. A multicentre study of oral paracoccidioidomycosis: analysis of 320 cases and literature review. Oral Dis. 2018;24:1492-502.

https://doi.org/10.1111/odi.12925

PMid:29949225 

23. Bicalho RN, Espírito Santo MF, Aguiar MCF, Santos VR. Oral paracoccidioidomycosis: a retrospective study of 62 Brazilian patients. Oral Dis. 2001;7:56-60.

https://doi.org/10.1034/j.1601-0825.2001.70111.x

PMid:11354923 

24. Ramos-e-Silva M, Saraiva LES. Paracoccidioidomycosis. Dermatol Clin. 2008;26:257-69.

https://doi.org/10.1016/j.det.2007.11.005

PMid:18346557 

25. Azenha MR, Caliento R, Brentegani LG, Lacerda SA. A retrospective study of oral manifestations in patients with paracoccidioidomycosis. Braz Dent J. 2012;23:753-7.

https://doi.org/10.1590/S0103-64402012000600021

PMid:23338272 

26. Kaminagakura E, Bonan PR, Jorge J, Almeida OP, Scully C. Characterization of inflammatory cells in oral paracoccidioidomycosis. Oral Dis. 2007;13:434-9.

https://doi.org/10.1111/j.1601-0825.2006.01319.x

PMid:17577332 

27. Abreu e Silva MA, Salum FG, Figueiredo MA, Cherubini K. Important aspects of oral paracoccidioidomycosis- a literature review. Mycoses. 2013;56:189-99.

https://doi.org/10.1111/myc.12017

PMid:23088400 

28. Carli ML, Miyazawa M, Nonogaki S, Shirata NK, Oliveira DT, Pereira AA, et al. M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis. J Oral Pathol Med. 2016;45:141-7.

https://doi.org/10.1111/jop.12333

PMid:26041558 

29. Pedreira RPG, Carli ML, Beijo LA, Nonogaki S, Pereira AA, Junior NV, et al. Oral paracoccidioidomycosis granulomas are predominantly populated by CD163+ multinucleated giant cells. Mycopathologia. 2016;181:709-16.

https://doi.org/10.1007/s11046-016-0016-5

PMid:27236303 

30. Santos LFM, Melo NB, Carli ML, Mendes ACSC, Bani GMAC, Verinaud LM, et al. Photodynamic inactivation of Paracoccidioides brasiliensis helps the outcome of oral paracoccidiodomycosis. Lasers Med Sci. 2017;32:921-30.

https://doi.org/10.1007/s10103-017-2193-y

PMid:28349345